P
This company provides FDA-cleared software that collects real-world clinical data for cardiology applications. The platform unites patients, providers, and researchers to deliver high-density clinical insights for better treatment decisions and accelerated drug development. Its advanced algorithms simplify research workflows and enhance the confidence in cardiovascular study results.
Updated 4 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- Prolaio provides a connected platform that continuously monitors cardiovascular health data, enabling patients and care teams to make timely, informed decisions about treatment. This approach addresses the challenge of infrequent doctor visits by facilitating real-time insights, reducing hospital readmissions, and improving overall patient outcomes.